For the “signaling by receptor tyrosine kinases” pathway, several studies have suggested that high levels of receptor tyrosine kinases (RTKs) may be associated with increased breast cancer aggressiveness and decreased overall and disease-free survival [55–60]. Here, NTRK1 is linked to breast cancer.